Roles of Fc receptors in autoimmunity

Nature Reviews Immunology

Volumn 2, Issue 8, 2002, Pages 580-592

  Takai, Toshiyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ALLERGIC ENCEPHALITIS; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING SITE; CELLULAR IMMUNITY; CRYOGLOBULINEMIA; DERMATOMYOSITIS; GENETIC POLYMORPHISM; GOODPASTURE SYNDROME; GRAFT VERSUS HOST REACTION; GUILLAIN BARRE SYNDROME; HEMOLYTIC ANEMIA; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LIGAND BINDING; MOUSE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEITIS; WEGENER GRANULOMATOSIS; ANIMAL; GENETICS; IMMUNOLOGY;

ANIMALS; AUTOIMMUNITY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, FC; SIGNAL TRANSDUCTION;

EID: 0036676975     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri856     Document Type: Review

References (121)

1. Sinclair, N. R., Lees, R. K. & Elliott, E. V. Role of the Fc fragment in the regulation of the primary immune response. Nature 220, 1048-1049 (1968).
2. Sinclair N. R. Fc-signalling in the modulation of immune responses by passive antibody. Scand. J. Immunol. 53, 322-330 (2001). This paper provides an historical overview of antibody-mediated activation and suppression of immune responses.
3. Paraskevas, F., Lee, S. T., Orr, K. B. & Israels, G. A receptor for Fc on mouse B lymphocytes. J. Immunol. 108, 1319-1327 (1972).
4. Amigorena, S. & Bonnerot, C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol. Rev. 172, 279-284 (1999).
5. Fridman, W. H. et al. Structural bases of Fcγ receptor functions. Immunol. Rev. 125, 49-76 (1992).
6. Durum, S. K., Lee, C.-K., Geiman, T. M., Murphy, W. J. & Muegge, K. CD16 cross-linking blocks rearrangement of the TCRβ locus and development of αβ T cells and induces development of NK cells from thymic progenitors. J. Immunol. 161, 3325-3329 (1998).
7. de Andres, B., Mueller, A. L., Verbeek, S., Sandor, M. & Lynch, R. G. A regulatory role for Fcγ receptors CD16 and CD32 in the development of murine B cells. Blood 92, 2823-2829 (1998).
8. Kato, I., Takai, T. & Kudo, A. FcγRIIB negatively regulates the pre-BCR signaling for apoptosis. J. Immunol. 168, 629-634 (2002).
9. Takai, T., Li, M., Sylvestre, D., Clynes, R. & Ravetch, J. V. FcR γ-chain deletion results in pleiotrophic effector-cell defects. Cell 76, 519-529 (1994). Describes multiple immune-system defects in FcRγ -deficient mice.
10. Sylvestre, D. L. & Ravetch, J. V. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265, 1095-1098 (1994). Opens the discussion on the dominant role of Fc receptors over complement.
11. Clynes, R. & Ravetch, J. V. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3, 21-26 (1995).
12. Clynes, R. et al. Modulation of immune-complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189, 179-186 (1999).
13. Sylvestre, D. L. & Ravetch, J. V. A dominant role for mast-cell Fc receptors in the Arthus reaction. Immunity 5, 387-390 (1996).
14. Hazenbos, W. L. W. et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16)-deficient mice. Immunity 5, 181-188 (1996). The first description of the phenotypes of FcγRIII-deficient mice.
15. Ujike, A. et al. Modulation of IgE-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189, 1573-1579 (1999).
16. Barnes, N. et al. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16, 379-389 (2002).
17. Ioan-Facsinay, A. et al. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16, 391-402 (2002). References 16 and 17 describe several noteworthy aspects of FcγRI-deficient mice.
18. Takai, T., Ono, M., Hikida, M., Ohmori, H. & Ravetch, J. V. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379, 346-349 (1996). The first description of FcγRIIb-deficient mice, showing that FcγRIIb is an inhibitory receptor in vivo.
19. van de Winkel, J. G. J. & Capel, P. J. A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 14, 215-221 (1993).
20. Shibuya, A. et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nature Immunol. 1, 441-446 (2000).
21. Launay, P. et al. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191, 1999-2009 (2000).
22. McDonald, K. J., Cameron, A. J., Allen, J. M. & Jardine, A. G. Expression of Fcα/μ receptor by human mesangial cells: a candidate receptor for immune-complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290, 438-442 (2002).
23. Davis, R. S., Wang, Y.-H., Kubagawa, H. & Cooper, M. D. Identification of a family of Fc-receptor homologs with preferential B-cell expression. Proc. Natl Acad. Sci. USA 98, 9772-9777 (2001).
24. Hatzivassiliou, G. et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B-cell malignancy. Immunity 14, 277-289 (2001).
25. Rigby L. J. et al. Domain one of the high-affinity IgE receptor, FcεRI, regulates binding to IgE through its interface with domain two. J. Biol. Chem. 275, 9664-9672 (2000).
26. Rigby L. J. et al. Monoclonal antibodies and synthetic peptides define the active site of FcγRI and a potential receptor antagonist. Allergy 55, 609-619 (2000).
27. Sondermann, P., Huber, R., Oosthuizen, V. & Jacob, U. The 3. 2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406, 267-273 (2000). Detailed three-dimensional structural analysis of the FcγR-IgG interaction, providing an insight into the unique binding stoichiometry of FcγRs and IgG.
28. Takai, T. & Ravetch, J. V. In Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity (eds van de Winkel, J. G. J. & Hogarth, P. M.) 37-48 (Kluwer Academic Publishers, Netherlands, 1998).
29. Ravetch, J. V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84-89 (2000). Provides an intriguing overview of inhibitory receptors in Fc- and NK-receptor families.
30. Takai, T. & Ono, M. Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol. Rev. 181, 215-222 (2001).
31. Ravetch, J. V. & Clynes, R. A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16, 421-432 (1998). An excellent review of the crucial roles of Fc receptors in immunity.
32. Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290 (2001).
33. Wang, A. V., Scholl, P.R. & Geha, R. S. Physical and functional association of the high-affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn, J. Exp. Med. 180, 1165-1170 (1994).
34. Ghazizadeh, S., Bolen, J. B. & Fleit, H. B. Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells. J. Biol. Chem. 269, 8878-8884 (1994).
35. H2 cytokines. J. Immunol. 166, 531-537 (2001).
36. Kwiatkowska, K. & Sobota, A. The clustered Fcγ receptor II is recruited to Lyn-containing membrane domains and undergoes phosphorylation in a cholesterol-dependent manner. Eur. J. Immunol. 31, 989-998 (2001).
37. Muta, T. et al. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell-receptor signalling. Nature 368, 70-73 (1994).
38. D'Ambrosio, D. et al. Recruitment and activation of PTP-1C in negative regulation of antigen-receptor signaling by FcγRIIB1. Science 268, 293-297 (1995).
39. Damen, J. E. et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl Acad. Sci. USA 93, 1689-1693 (1996).
40. Ono, M., Bolland, S., Tempst, P. & Ravetch, J. V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383, 263-266 (1996). Demonstrates, for the first time, the recruitment of SHIP to FcγRIIB.
41. Ono, M. et al. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90, 293-301 (1997).
42. Fong, D. C. et al. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast-cell activation. Immunol. Lett. 54, 83-91 (1996).
43. Gupta, N. et al. Negative signaling pathways of the killer-cell inhibitory receptor and FcγRIIb1 require distinct phosphatases. J. Exp. Med. 186, 473-478 (1997).
44. Nakamura, K., Brauweiler, A. & Cambier, J. C. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on FcγRIIB1-effector interactions and inhibitory functions. J. Immunol. 164, 631-638 (2000).
45. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17, 1961-1972 (1998).
46. 2+ following B-cell-receptor activation. EMBO J. 17, 1973-1985 (1998).
47. Bolland, S., Pearse, R. N., Kurosaki, T. & Ravetch, J. V. SHIP modulates immune-receptor responses by regulating membrane association of Btk. Immunity 8, 509-516 (1998).
48. Liu, Q. et al. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B-cell antigen-receptor signaling. J. Exp. Med. 186, 1333-1342 (1998).
49. Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T. & Ravichandran, K. S. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 273, 33922-33928 (1998).
50. -/- mice. J. Exp. Med. 191, 781-794 (2000).
51. Tridandapani, S. et al. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcγ immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17, 4305-4311 (1997).
52. dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12, 347-358 (2000).
53. Tridandapani, S., Chacko, G. W., Van Brocklyn, J. R. & Coggeshall, K. M. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. J. Immunol. 158, 1125-1132 (1997).
54. Hashimoto, A. et al. Involvement of guanosine triphosphatases and phospholipase C-y2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B-cell antigen receptor. J. Exp. Med. 188, 1287-1295 (1998).
55. dok in negative regulation of B-cell-receptor-mediated signaling. Genes Dev. 14, 11-16 (2000). Demonstrates the crucial role of Dok in FcγRIIb-mediated B-cell inhibition using Dok-deficient mice.
56. 2- mobilization is integrated by CD19 dephosphorylation. Immunity 7, 49-58 (1997).
57. Ashman, R. F., Peckham, D. & Stunz, L. L. Fc receptor off-signal in the B cell involves apoptosis. J. Immunol. 157, 5-11 (1996).
58. Pearse, R. N. et al. SHIP recruitment attenuates FcγRIIB-induced B-cell apoptosis. Immunity 10, 753-760 (1999). Introduces the unexpected role of FcγRIIB in inducing apoptosis in B cells.
59. Regnault, A. et al. Fcγ-receptor-mediated induction of dendritic-cell maturation and major histocompatibility complex class-I-restdcted antigen presentation after immune-complex internalization. J. Exp. Med. 189, 371-380 (1999). Provides evidence of the important role of FcγRs on dendritic cells for the enhancement of antigen presentation.
60. Booth, J. W., Kim, M.-K., Jankowski, A., Schreiber, A. D. & Grinstein, S. Contrasting requirements for ubiquitylation during Fc-receptor-mediated endocytosis and phagocytosis. EMBO J. 21, 251-258 (2002).
61. Machy, P., Serre, K. & Leserman, L. Class-I-restricted presentation of exogenous antigen acquired by Fcγ-receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30, 848-857 (2000).
62. H-cell responses. J. Immunol. 164, 6113-6119 (2000).
63. Watanabe, N. et al. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor-necrosis factor production upon triggering Fcγ receptors. Blood 94, 3855-3863 (1999).
64. Hazenbos, W. L. W. et al. Murine IgG1 complexes trigger immune effector functions predominantly via FcγRIII (CD16). J. Immunol. 161, 3026-3032 (1998).
65. Clynes, R., Dumitru, C. & Ravetch, J. V. Uncoupling of immune-complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052-1054 (1998).
66. Suzuki, Y. et al. Distinct contribution of Fc receptors and angiotensin-II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. 54, 1166-1174 (1998).
67. Park, S. Y. et al. Resistance of Fc-receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102, 1229-1238 (1998).
68. Dombrowicz, D. et al. Absence of FcεRI α-chain results in upregulation of FcγRIII-dependent mast-cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β- and γ-chain. J. Clin. Invest. 99, 915-925 (1997).
69. Dombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H. & Kinet, J.-P. Abolition of anaphylaxis by targeted disruption of the high-affinity immunoglobulin E receptor α-chain gene. Cell 75, 969-976 (1993).
70. Schiller, C. et al. Mouse FcγRII is a negative regulator of FcγRIII in IgG immune-complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur. J. Immunol. 30, 481-490 (2000).
71. Kleinau, S., Martinsson, P. & Heyman, B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J. Exp. Med. 191, 1611-1616 (2000).
72. b mice susceptible to collagen-induced arthritis. J. Exp. Med. 189, 187-194 (1999).
73. Jiang, Y. et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51, 429-435 (2000).
74. Pritchard, N. R. et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10, 227-230 (2000).
75. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Marten, A. & Mosedale, B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666-668 (1980).
76. Svensson, L., Jirholt, J., Holmdahl, R. & Jansson, L. B-cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111, 521-526 (1998).
77. Stuart, J. M. & Dixon, F. J. (1983) Serum transfers of collagen-induced arthritis in mice. J. Exp. Med. 158, 378-392 (1983).
78. Wooley, P. H., Luthra, H. S., Stuart, J. M. & David, S. C. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates. J. Exp. Med. 154, 688-700 (1981).
79. Holmdahl, R. et al. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 118, 193-232 (1990).
80. Kalluri, R. Goodpasture syndrome. Kidney Int. 55, 1120-1122 (1999).
81. Savage, C. O., Pusey, C. D., Bowman, C., Rees, A. J. & Lockwood, C. M. Antiglomerular basement membrane antibody-mediated disease in the British Isles. BMJ 292, 1980-1984 (1996).
82. Nakamura, A. et al. Fcγ-receptor-IIB-defcient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. 191, 899-906 (2000).
83. Bolland, S. & Ravetch, J. V. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277-285 (2000). References 12, 71, 72, 82 and 83 describe the direct relationship of FcγRIIb defects with different types of autoimmunity.
84. -/- mice. J. Exp. Med. 195, 1167-1174 (2002).
85. Luan, J. J. et al. Defective FcγRII gene expression in macrophages of NOD mice: genetic linkage with upregulation of IgG1 and IgG2b in serum. J. Immunol. 157, 4707-4716 (1996).
86. Jordan, M. A. et al. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J. Immunol. 165, 1673-1684 (2000).
87. Myhr, K. M., Raknes, G., Nyland, H. & Vedeler, C. Imunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS. Neurology 52, 1771-1776 (1999).
88. Abdul-Majid, K.-B. et al. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scan. J. Immunol. 55, 70-81 (2002). Indicates the importance of FcγRs to T-cell-mediated autoimmunity, such as EAE.
89. Bakker, A. B. H. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345-353 (2000).
90. Tomasello, E. et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13, 355-364 (2000).
91. Kyogoku, C. et al. Association of Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to the genetic susceptibility to SLE. Arthritis Rheum. 46, 1242-1254 (2002). Describes FcγRIIB polymorphisms and their relation to SLE.
92. Salmon, E. & Kimberly, R. P. In The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity (eds van de Winkel, J. G. J. & Hogarth, P. M.) 267-278 (Kluwer Academic Publishers, Great Britain, 1998).
93. Salmon, J. E. & Pricop, L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 44, 739-750 (2001).
94. Duits, A. J. et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 38, 1832-1836 (1995).
95. Salmon, J. E. et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97, 1348-1354 (1996).
96. Song, Y. W. et al. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 41, 421-426 (1998).
97. Koene, H. R. et al. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 41, 1813-1818 (1998).
98. Wu, J. et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100, 1059-1070 (1997).
99. Salmon, J. E., Kimberly, R. P., Gibofsky, A. & Fotino, M. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc-receptor ligand binding and internalization. J. Immunol. 133, 2525-2531 (1984).
100. Hatta, Y. et al. Association of Fcγ receptor IIIB, but not of Fcγ receptor IIA and IIIA, polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. 1, 53-60 (1999).
101. Nieto, A. et al. Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum. 43, 735-739 (2000).
102. Wainstein, E. et al. The neutrophil FcγRIIIB is associated with renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum. 39, S210 (1996).
103. Vedeler, C. A., Raknes, G., Myhr, K. M. & Nyland, H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology 55, 705-707 (2000).
104. Botto, M. et al. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin. Exp. Immunol. 104, 264-268 (1996).
105. Oh, M. et al. Frequency of the FcγRIIIA-158F allele in African American patients with systemic lupus erythematosus. J. Rheumatol. 26, 1486-1489 (1999).
106. Tax, W. J. M., Willems, H. W., Reekers, P. P. M., Capel, P. J. A. & Koene, R. A. P. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304, 445-447 (1983).
107. Lalezari, P. In Immunohaematology (eds Engelfreet, C. P., Van Loghem, J. J., Kr, A. E. G.) 33 (Elsevier Science, Amsterdam, 1984).
108. Salmon, J. E., Edberg, J. C. & Kimberly, R. P. Fcγ receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 85, 1287-1295 (1990).
109. Yasuda, K., Sugita, N., Yamamoto, K., Kobayashi, T. & Yoshie, H. Seven single nucleotide substitutions in human Fcγ receptor IIB gene. Tissue Antigens 58, 339-342 (2001).
110. Gelfand, E. W. Antibody-directed therapy: past, present and future. J. Allergy Clin. Immunol. 108, S111-S116 (2001).
111. Samuelsson, A., Towers, T. & Ravetch, J. V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291, 484-486 (2001). Describes the intriguing observation of FcγRIIb upregulation in macrophages after IVIG treatment in mice.
112. Yamazaki, T. et al. Essential immunoregulatory role for BCAP in B-cell development and function. J. Exp. Med. 195, 535-545 (2002).
113. Wagle, N. M., Faassen, A. E., Kim, J. H. & Pierce, S. K. Regulation of B-cell-receptor-mediated MHC class II antigen processing by FcγRIIB1. J. Immunol. 162, 2732-2740 (1999).
114. Rudge, E. R., Cutler, A. J., Pritchard, N. R. & Smith, K. G. C. Interleukin-4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B-cell suppression. J. Exp. Med. 195, 1079-1085 (2002).
115. Dombrowicz, D. et al. Allergy-associated FcRβ is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 8, 517-529 (1998).
116. Yu, P., Kosco-Vilbois, M., Richards, M., Kohler, G. & Lamers, M. C. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369, 753-756 (1994).
117. 2-microglobulin: possible protective role of FcRn. Immunology 89, 573-578 (1996).
118. 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J. Immunol. 159, 4781-4792 (1997).
119. Shimada, S. et al. Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J. Immunol. 163, 5367-5373 (1999).
120. de Haas, M., Kleijer, M., van Zwieten, R., Roos, D. & von dem Borne, A. E. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 86, 2403-2413 (1995).
121. van de Winkel, J. G., de Wit, T. P., Ernst, L. K., Capel, P. J. & Ceuppens, J. L. Molecular basis for a familial defect in phagocyte expression of IgG receptor I (CD64). J. Immunol. 154, 2896-2903 (1995).